Wealthfront Advisers LLC boosted its position in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 7.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,782 shares of the financial services provider's stock after acquiring an additional 4,531 shares during the period. Wealthfront Advisers LLC's holdings in Aflac were worth $7,203,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of AFL. Golden State Wealth Management LLC lifted its position in Aflac by 121.9% during the first quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock valued at $34,000 after purchasing an additional 167 shares during the last quarter. Garde Capital Inc. bought a new stake in Aflac during the first quarter valued at approximately $36,000. Capital A Wealth Management LLC bought a new stake in Aflac during the fourth quarter valued at approximately $38,000. NBC Securities Inc. bought a new stake in Aflac during the first quarter valued at approximately $44,000. Finally, JCIC Asset Management Inc. bought a new stake in Aflac during the first quarter valued at approximately $44,000. Hedge funds and other institutional investors own 67.44% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts have issued reports on the stock. Barclays set a $98.00 target price on shares of Aflac and gave the company an "underweight" rating in a research report on Monday, July 7th. Raymond James Financial dropped their target price on shares of Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a research report on Thursday, May 29th. Keefe, Bruyette & Woods lifted their price target on shares of Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research note on Wednesday, May 7th. UBS Group lifted their price target on shares of Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 2nd. Finally, Piper Sandler lifted their price target on shares of Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, Aflac presently has a consensus rating of "Hold" and an average target price of $107.07.
Read Our Latest Research Report on AFL
Insider Transactions at Aflac
In other news, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction dated Thursday, May 8th. The shares were sold at an average price of $106.79, for a total value of $106,790.00. Following the sale, the director directly owned 26,096 shares of the company's stock, valued at $2,786,791.84. This represents a 3.69% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Arthur Reginald Collins sold 2,750 shares of the company's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the completion of the sale, the director directly owned 6,728 shares in the company, valued at $711,149.60. This represents a 29.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 40,750 shares of company stock valued at $4,304,295 in the last three months. 0.90% of the stock is currently owned by company insiders.
Aflac Stock Up 0.4%
Shares of NYSE:AFL traded up $0.36 during midday trading on Friday, reaching $101.78. The company's stock had a trading volume of 4,577,769 shares, compared to its average volume of 2,153,065. The firm has a 50 day moving average of $103.33 and a 200-day moving average of $105.18. The firm has a market capitalization of $55.03 billion, a P/E ratio of 15.90, a PEG ratio of 3.15 and a beta of 0.81. The company has a quick ratio of 0.09, a current ratio of 0.09 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12-month low of $93.00 and a 12-month high of $115.50.
Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The business had revenue of $3.40 billion during the quarter, compared to analysts' expectations of $4.53 billion. Aflac had a return on equity of 15.55% and a net margin of 21.27%. The firm's quarterly revenue was down 37.5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.66 earnings per share. On average, research analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were given a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date was Wednesday, May 21st. Aflac's dividend payout ratio is presently 36.25%.
About Aflac
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles

Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.